Furthermore, several studies reported positive correlations between circulating IL-18 levels and inflammation, liver injury, fibrosis or the severity of the disease (Table 1), positioning IL-18 as a reliable biomarker to predict NASH diagnosis [141,142,143]. This evidence concerns the gene IL18 and metabolic dysfunction-associated steatohepatitis.